"Glycosaminoglycans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE).
| Descriptor ID |
D006025
|
| MeSH Number(s) |
D09.698.373
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glycosaminoglycans".
Below are MeSH descriptors whose meaning is more specific than "Glycosaminoglycans".
This graph shows the total number of publications written about "Glycosaminoglycans" by people in this website by year, and whether "Glycosaminoglycans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 3 | 4 |
| 2018 | 1 | 4 | 5 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Glycosaminoglycans" by people in Profiles.
-
A glycosaminoglycan microarray identifies the binding of SARS-CoV-2 spike protein to chondroitin sulfate E. FEBS Lett. 2021 09; 595(18):2341-2349.
-
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin. Cells. 2021 06 07; 10(6).
-
Anticoagulant Treatment of COVID-19 as Early as Possible-Sulodexide and Perspectives. Thromb Haemost. 2021 07; 121(7):849-853.
-
Thrombohaemorhhagic balance in coronavirus disease 2019 and its management: a perspective. Blood Coagul Fibrinolysis. 2021 Apr 01; 32(3):167-171.
-
Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial. Thromb Haemost. 2021 Jul; 121(7):944-954.
-
How glycobiology can help us treat and beat the COVID-19 pandemic. J Biol Chem. 2021 Jan-Jun; 296:100375.
-
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly. Semin Thromb Hemost. 2021 06; 47(4):348-350.
-
Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:1076029620977702.
-
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:10760296211021498.
-
Sulodexide may be a real alternative to low molecular weight heparins in the prevention of COVID-19 induced vascular complications. Dermatol Ther. 2020 11; 33(6):e14437.